These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36436757)

  • 21. Evaluation of electrospun PLLA/PEGDMA polymer coatings for vascular stent material.
    Boodagh P; Guo DJ; Nagiah N; Tan W
    J Biomater Sci Polym Ed; 2016 Aug; 27(11):1086-99. PubMed ID: 27137629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
    Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
    Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-Mimicking Multifunctional Coating Modified Cardiovascular Stents via a Stepwise Metal-Catechol-(Amine) Surface Engineering Strategy.
    Yang Y; Gao P; Wang J; Tu Q; Bai L; Xiong K; Qiu H; Zhao X; Maitz MF; Wang H; Li X; Zhao Q; Xiao Y; Huang N; Yang Z
    Research (Wash D C); 2020; 2020():9203906. PubMed ID: 32405627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citric acid functionalized nitinol stent surface promotes endothelial cell healing.
    Ceresnakova M; Murray D; McGourty KD; Butler J; Neilan J; Soulimane T; Hudson SP
    J Biomed Mater Res A; 2021 Sep; 109(9):1549-1559. PubMed ID: 33624931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.
    Kural MH; Wang J; Gui L; Yuan Y; Li G; Leiby KL; Quijano E; Tellides G; Saltzman WM; Niklason LE
    Biomaterials; 2019 Aug; 212():28-38. PubMed ID: 31102854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
    Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
    Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mussel adhesive protein fused with VE-cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent.
    Yang D; Yan W; Qiu J; Huang Y; Li T; Wang Y; Wang N; Durkan C; Huang J; Yin T; Wang G
    J Biomed Mater Res B Appl Biomater; 2020 Jan; 108(1):94-103. PubMed ID: 30974041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tannic acid-modified fluoride pre-treated Mg-Zn-Y-Nd alloy with antioxidant and platelet-repellent functionalities for vascular stent application.
    Wang P; Liu J; Luo X; Xiong P; Gao S; Yan J; Li Y; Cheng Y; Xi T
    J Mater Chem B; 2019 Dec; 7(46):7314-7325. PubMed ID: 31674636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces.
    Yang Z; Zhao X; Hao R; Tu Q; Tian X; Xiao Y; Xiong K; Wang M; Feng Y; Huang N; Pan G
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16127-16137. PubMed ID: 32601214
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Hertault A; Chai F; Maton M; Sobocinski J; Woisel P; Maurel B; Lyskawa J; Blanchemain N
    Biomater Sci; 2021 Jan; 9(1):212-220. PubMed ID: 33179639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
    Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
    Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro.
    Kastl SP; Katsaros KM; Krychtiuk KA; Jägersberger G; Kaun C; Huber K; Wojta J; Speidl WS
    PLoS One; 2020; 15(5):e0232483. PubMed ID: 32392256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.
    Lan H; Wang Y; Yin T; Wang Y; Liu W; Zhang X; Yu Q; Wang Z; Wang G
    J Biomed Mater Res B Appl Biomater; 2016 Aug; 104(6):1237-47. PubMed ID: 26059710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
    Curcio A; Torella D; Indolfi C
    Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug loaded nanoparticle coating on totally bioresorbable PLLA stents to prevent in-stent restenosis.
    Zhao J; Mo Z; Guo F; Shi D; Han QQ; Liu Q
    J Biomed Mater Res B Appl Biomater; 2018 Jan; 106(1):88-95. PubMed ID: 27875036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
    Holy EW; Jakob P; Eickner T; Camici GG; Beer JH; Akhmedov A; Sternberg K; Schmitz KP; Lüscher TF; Tanner FC
    Eur Heart J; 2014 Mar; 35(12):808-20. PubMed ID: 24334406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo.
    Diaz-Rodriguez S; Rasser C; Mesnier J; Chevallier P; Gallet R; Choqueux C; Even G; Sayah N; Chaubet F; Nicoletti A; Ghaleh B; Feldman LJ; Mantovani D; Caligiuri G
    Eur Heart J; 2021 May; 42(18):1760-1769. PubMed ID: 33580685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.